Fund Holdings — Saturn V Capital Management LP

Total Portfolio Value:
$683.13M
Total Bought:
$101.58M
Total Sold:
$140.66M
Net Transaction:
-$39.08M
Notable People:
Xiaoying (Nmn) Tian, Douglas Kevin Edwards
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Amylyx Pharmaceuticals, Inc.(AMLX)4,624,1014,471,356-152,745$83.05M$130.12M19.05%+$47.07M
ABIVAX Société AnonymeADS(ABVX)518,865529,313+10,448$69.14M$52.41M7.67%-$16.73M
Immix Biopharma Inc4,658,4294,661,115+2,686$48.03M$48.50M7.10%+$470.5K
Pharvaris N V
COM
1,314,1221,393,956+79,834$45.44M$44.22M6.47%-$1.23M
Vaxcyte, Inc.(PCVX)852,914772,258-80,656$49.58M$43.94M6.43%-$5.64M
Celcuity Inc.(CELC)370,318513,847+143,529$38.74M$40.86M5.98%+$2.12M
Disc Medicine, Inc.(IRON)524,730612,661+87,931$38.38M$40.10M5.87%+$1.73M
Candel Therapeutics Inc3,303,6863,476,206+172,520$34.03M$36.29M5.31%+$2.26M
Jazz Pharmaceuticals plcSHS USD(JAZZ)160,938150,340-10,598$38.78M$34.81M5.10%-$3.97M
Monopar Therapeutics Inc311,976312,350+374$28.89M$24.88M3.64%-$4.00M
Vir Biotechnology, Inc.(VIR)770,6432,040,422+1,269,779$7.85M$22.81M3.34%+$14.96M
Trevi Therapeutics, Inc.(TRVI)1,052,0431,573,876+521,833$19.62M$22.54M3.30%+$2.92M
X4 Pharmaceuticals Inc6,973,3437,366,442+393,099$32.57M$21.36M3.13%-$11.20M
Alumis Inc2,915,4432,855,811-59,632$82.04M$21.10M3.09%-$60.94M
Sagimet Biosciences IncCOM SER A1,479,9182,002,813+522,895$11.44M$19.79M2.90%+$8.35M
Dyne Therapeutics, Inc.(DYN)1,057,493837,175-220,318$23.49M$13.49M1.97%-$10.00M
Alto Neuroscience, Inc.(ANRO)182,829518,109+335,280$4.82M$13.23M1.94%+$8.40M
Ultragenyx Pharmaceutical Inc.(RARE)0758,771+758,771$0$11.40M1.67%+$11.40M
Zura Bio LtdCL A2,101,1192,032,454-68,665$12.40M$8.46M1.24%-$3.94M
Inhibikase Therapeutics Inc3,869,0563,869,0560$7.85M$7.95M1.16%+$96.7K
Oculis Holding Ag684,880847,444+162,564$9.50M$7.92M1.16%-$1.58M
Erasca, Inc.(ERAS)0514,309+514,309$0$7.54M1.10%+$7.54M
Latigo Biotherapeutics Inc0300,355+300,355$0$5.02M0.73%+$5.02M
Satellos Bioscience Inc350,000516,800+166,800$2.72M$4.39M0.64%+$1.67M
Invivyd, Inc.(IVVD)8,392,2880-8,392,288$7.32M$0—-$7.32M
Ovid Therapeutics Inc.(OVID)663,0600-663,060$1.78M$0—-$1.78M
Page 1 of 1